New technique may spare tiniest babies from breathing tubes

NCT ID NCT04715373

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a method called LISA (Less Invasive Surfactant Administration) in extremely preterm infants (22-25 weeks). Instead of inserting a breathing tube, doctors gave lung medication through a thin catheter while the baby continued on CPAP. The goal was to see if this approach reduces the need for mechanical ventilation in the first 72 hours of life. Sixty infants were enrolled, and the study compared those who received LISA in the delivery room to those who got standard care.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Poractant alfa (a natural lung surfactant) given via a thin catheter while the baby stays on CPAP
What this could lead to
If it works, this approach could help extremely preterm babies breathe with less invasive support, potentially lowering the risk of lung damage and other complications.
What could go wrong
This is a small, early feasibility trial with only 60 babies, so results may not apply to all preterm infants. The procedure itself carries risks, such as incorrect catheter placement or breathing instability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTREME PREMATURITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Venkatakrishna Kakkilaya

    Dallas, Texas, 75093, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.